Although initial surgery has been reported to extend overall survival (OS), the benefits may not be significant, and rapid tumor recurrence post-surgery is common ( 1 ).
← all excerpts
A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review.
1
—
—